uniQure QURE
NASDAQ QURE
$38.32 -4.44 (-10.38%)
At close: Sep 24, 2026 · 4:00 PM EDT

uniQure (QURE) Research & Development (2016 - 2026)

uniQure (QURE) posted Research & Development of $34.0 million for Q2 2026, up 16.41% on a QoQ basis from $29.2 million in Q1 2026, and down 4.01% year-over-year from $35.4 million in Q2 2025.

Analysis

uniQure (QURE) Research & Development (2016 - 2026) Analysis & Trends

uniQure has reported Research & Development for 11 years, with the latest figure at $34.0 million in Q2 2026.

  • On a quarterly basis, Research & Development fell 4.01% year-over-year to $34.0 million in Q2 2026; TTM through Jun 2026 was $132.3 million, a 6.15% decrease from a year earlier, with the FY2025 full-year figure at $140.7 million, down 2.16% from the prior year.
  • Research & Development was $34.0 million for Q2 2026 at uniQure, up from $29.2 million in the prior quarter.
  • The five-year high for Research & Development was $65.4 million in Q3 2023, with the low at $29.2 million in Q1 2026.
  • Average Research & Development over 5 years is $42.2 million, with a median of $39.8 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2024: Research & Development jumped 41.06% in 2022, then slumped 53.22% in 2024.
  • Over 5 years, Research & Development stood at $58.3 million in 2022, then retreated by 26.93% to $42.6 million in 2023, then slipped by 8.87% to $38.8 million in 2024, then slipped by 10.44% to $34.8 million in 2025, then decreased by 2.36% to $34.0 million in 2026.
  • The last three Research & Development figures came in at $34.0 million (Q2 2026), $29.2 million (Q1 2026), and $34.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn 3.65 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn 2.34 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn -2.85 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn -4.05 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn 1.87 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn 1.76 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn 2.81 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn 993.80 Mn
10 uniQure 2.96 Bn 2.96 Bn 5.49 Mn 33.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 33.96 Mn
Mar 31, 2026 29.18 Mn
Dec 31, 2025 34.78 Mn
Sep 30, 2025 34.37 Mn
Jun 30, 2025 35.38 Mn
Mar 31, 2025 36.14 Mn
Dec 31, 2024 38.84 Mn
Sep 30, 2024 30.60 Mn
Jun 30, 2024 33.66 Mn
Mar 31, 2024 40.69 Mn
Dec 31, 2023 42.62 Mn
Sep 30, 2023 65.40 Mn
Jun 30, 2023 46.04 Mn
Mar 31, 2023 60.81 Mn
Dec 31, 2022 58.33 Mn
Sep 30, 2022 48.07 Mn
Jun 30, 2022 46.19 Mn
Mar 31, 2022 45.00 Mn
Dec 31, 2021 42.34 Mn
Sep 30, 2021 36.43 Mn
API Access

uniQure Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=QURE&period=max&api_key=YOUR_API_KEY